1-12 of 12
Daniel Zelterman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract A002: A phase II study of peri-operative modified FOLFIRINOX in localized pancreatic ductal adenocarcinoma (PDAC)

Michael Cecchini, Ronald Salem, Marie Robert, Suzanne Czerniak, Moein Rajaei, Jeffrey Townsend, Ondrej Blaha, Daniel Zelterman, Jaykumar Thumar, Jeremy Kortmansky, Wajih Zaheer, Neal Fischbach, Justin Persico, Stacey Stein, Sajid Khan, Charles Cha, Kevin Billingsley, John Kunstman, Sumedha Chowdhury, Robert Tseng, Carlos Mauricio, Deanne Yugawa, Luisa Escobar-Hoyos, Kimberly Johung, Christina Wiess, Erik Spickard, Vasily N. Aushev, George Laliotis, Adham Jurdi, Minetta C. Liu, Jill Lacy
Journal: Cancer Research
Cancer Res (2024) 84 (2_Supplement): A002.
https://doi.org/10.1158/1538-7445.PANCA2023-A002
Published: 16 January 2024
View article titled, Abstract A002: A phase II study of peri-operative modified FOLFIRINOX in localized pancreatic ductal adenocarcinoma (PDAC)
Journal Articles

Abstract PS5-28: Multiomic advanced diagnostics for CDK 4/6 drug target activation mapping of HR+/HER2- metastatic breast cancer

Maysa M Abu-Khalaf, Christos Hatzis, K. Alex Hodge, Frances Valdes, William Sikov, Monica Mita, Neelima Denduluri, Kris Awerkamp, Rita Murphy, Daniel Zelterman, Bryant Dunetz, Emanuel Petricoin, Mariaelena Pierobon
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): PS5-28.
https://doi.org/10.1158/1538-7445.SABCS20-PS5-28
Published: 15 February 2021
View article titled, Abstract PS5-28: Multiomic advanced diagnostics for CDK 4/6 drug target activation mapping of HR+/HER2- metastatic breast cancer
Journal Articles

Abstract P5-13-02: Neoadjuvant aromatase inhibitor therapy plus the mTOR inhibitor everolimus in postmenopausal women with hormone receptor positive/HER2 negative breast cancer and an oncotype Dx recurrence score (≤25)

Maysa M Abu-Khalaf, Kimberly Aderhold, Michal Marczyk, Gina Chung, Erin Hofstatter, Tara Sanft, Andrea Silber, Michael DiGiovanna, Daniel Zelterman, Lajos Puzstai, Christos Hatzis
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): P5-13-02.
https://doi.org/10.1158/1538-7445.SABCS19-P5-13-02
Published: 15 February 2020
View article titled, Abstract P5-13-02: Neoadjuvant aromatase inhibitor therapy plus the mTOR inhibitor everolimus in postmenopausal women with hormone receptor positive/HER2 negative breast cancer and an oncotype Dx recurrence score (≤25)
Journal Articles

Abstract 2492: DNA polymerase beta participates in DNA end-joining

Sreerupa Ray, Michelle DeVeaux, Gregory Breuer, Ranjit Bindra, Daniel Zelterman, Joann Sweasy
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 2492.
https://doi.org/10.1158/1538-7445.AM2017-2492
Published: 01 July 2017
View article titled, Abstract 2492: DNA polymerase beta participates in DNA end-joining
Journal Articles

A KRAS-Variant in Ovarian Cancer Acts as a Genetic Marker of Cancer Risk

Elena Ratner, Lingeng Lu, Marta Boeke, Rachel Barnett, Sunitha Nallur, Lena J. Chin, Cory Pelletier, Rachel Blitzblau, Renata Tassi, Trupti Paranjape, Pei Hui, Andrew K. Godwin, Herbert Yu, Harvey Risch, Thomas Rutherford, Peter Schwartz, Alessandro Santin, Ellen Matloff, Daniel Zelterman, Frank J. Slack, Joanne B. Weidhaas
Journal: Cancer Research
Cancer Res (2010) 70 (16): 6509–6515.
https://doi.org/10.1158/0008-5472.CAN-10-0689
Published: 14 August 2010
View article titled, A <em>KRAS</em>-Variant in Ovarian Cancer Acts as a Genetic Marker of Cancer Risk
Open the PDF for A <em>KRAS</em>-Variant in Ovarian Cancer Acts as a Genetic Marker of Cancer Risk in another window
Includes: Supplementary data
Journal Articles

Abstract 464: Hypoxia-regulated Delta-like 1 homologue (DLK1) enhances cancer cell stemness and tumorigenicity

Yuri Kim, Qun Lin, Daniel Zelterman, Zhong Yun
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 464.
https://doi.org/10.1158/1538-7445.AM10-464
Published: 15 April 2010
View article titled, Abstract 464: Hypoxia-regulated Delta-like 1 homologue (DLK1) enhances cancer cell stemness and tumorigenicity
Journal Articles

Abstract 5324: Ablation of IL-17A abrogates progression of spontaneous intestinal tumorigenesis

Wook Jin Chae, Octavian Henegariu, Daniel Zelterman, Liming Hao, Thomas Gibson, Alfred Bothwell
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 5324.
https://doi.org/10.1158/1538-7445.AM10-5324
Published: 15 April 2010
View article titled, Abstract 5324: Ablation of IL-17A abrogates progression of spontaneous intestinal tumorigenesis
Journal Articles

Abstract 3029: A KRAS microRNA binding site polymorphism as a novel biomarker of risk in triple negative breast cancer

Trupti S. Paranjape, Helen Heneghan, Cory Pelletier, Aaron Hoffman, Michael J. Kerin, Lyndsay Harris, Yong Zhu, Nicola Miller, Daniel Zelterman, David Tuck, Frank Slack, Joanne Weidhaas
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 3029.
https://doi.org/10.1158/1538-7445.AM10-3029
Published: 15 April 2010
View article titled, Abstract 3029: A KRAS microRNA binding site polymorphism as a novel biomarker of risk in triple negative breast cancer
Journal Articles

Hypoxia-Regulated Delta-like 1 Homologue Enhances Cancer Cell Stemness and Tumorigenicity

Yuri Kim, Qun Lin, Daniel Zelterman, Zhong Yun
Journal: Cancer Research
Cancer Res (2009) 69 (24): 9271–9280.
https://doi.org/10.1158/0008-5472.CAN-09-1605
Published: 14 December 2009
View article titled, Hypoxia-Regulated Delta-like 1 Homologue Enhances Cancer Cell Stemness and Tumorigenicity
Open the PDF for Hypoxia-Regulated Delta-like 1 Homologue Enhances Cancer Cell Stemness and Tumorigenicity in another window
Includes: Supplementary data
Journal Articles

A SNP in a let-7 microRNA Complementary Site in the KRAS 3′ Untranslated Region Increases Non–Small Cell Lung Cancer Risk

Lena J. Chin, Elena Ratner, Shuguang Leng, Rihong Zhai, Sunitha Nallur, Imran Babar, Roman-Ulrich Muller, Eva Straka, Li Su, Elizabeth A. Burki, Richard E. Crowell, Rajeshvari Patel, Trupti Kulkarni, Robert Homer, Daniel Zelterman, Kenneth K. Kidd, Yong Zhu, David C. Christiani, Steven A. Belinsky, Frank J. Slack, Joanne B. Weidhaas
Journal: Cancer Research
Cancer Res (2008) 68 (20): 8535–8540.
https://doi.org/10.1158/0008-5472.CAN-08-2129
Published: 15 October 2008
View article titled, A SNP in a <em>let-7</em> microRNA Complementary Site in the <em>KRAS</em> 3′ Untranslated Region Increases Non–Small Cell Lung Cancer Risk
Open the PDF for A SNP in a <em>let-7</em> microRNA Complementary Site in the <em>KRAS</em> 3′ Untranslated Region Increases Non–Small Cell Lung Cancer Risk in another window
Includes: Supplementary data
Journal Articles

The Use of the l-Plastin Promoter for Adenoviral-mediated, Tumor-specific Gene Expression in Ovarian and Bladder Cancer Cell Lines1

Xue Yan Peng, Jong Ho Won, Thomas Rutherford, Takuma Fujii, Daniel Zelterman, Giuseppi Pizzorno, Eva Sapi, John Leavitt, Barry Kacinski, Ronald Crystal, Peter Schwartz, Albert Deisseroth
Journal: Cancer Research
Cancer Res (2001) 61 (11): 4405–4413.
Published: 01 June 2001
View article titled, The Use of the <sc>l</sc>-Plastin Promoter for Adenoviral-mediated, Tumor-specific Gene Expression in Ovarian and Bladder Cancer Cell Lines1
Open the PDF for The Use of the <sc>l</sc>-Plastin Promoter for Adenoviral-mediated, Tumor-specific Gene Expression in Ovarian and Bladder Cancer Cell Lines1 in another window
Journal Articles

Differences in Biological Activity among Batches of Lyophilized Tice Bacillus Calmette-Guérin and Their Association with Clinical Course in Stage I Lung Cancer

James A. Bennett, Howard Gruft, Martin F. McKneally, Daniel Zelterman, Ray G. Crispen
Journal: Cancer Research
Cancer Res (1983) 43 (9): 4183–4190.
Published: 01 September 1983
View article titled, Differences in Biological Activity among Batches of Lyophilized Tice <em>Bacillus Calmette-Guérin</em> and Their Association with Clinical Course in Stage I Lung Cancer
Open the PDF for Differences in Biological Activity among Batches of Lyophilized Tice <em>Bacillus Calmette-Guérin</em> and Their Association with Clinical Course in Stage I Lung Cancer in another window